For oxygen administration, high concentration respiratory masks are used. These are used to provide high concentration oxygen therapy to patients with incontinence and those in critical care. Various breathing and cardiac ailments can also be treated with emergency respiration. The oxygen concentration to be delivered consistently depends on the patient’s tidal volume and breathing rate, and high concentration respiratory masks have a reservoir bag with enough oxygen in it.
The oxygen concentration varies between 80 and 100 percent depending on the patient. In conditions such as Hypoxia, high concentration respiratory masks can help to alleviate breathing discomfort and pain. Non-rebreathing or partial masks are other names for high concentration respiratory masks. Patients do not even need breathing assistance when using non-rebreathing high concentration respiratory masks.
Approximately 12 million adults in the United States are diagnosed with chronic constructive pulmonary disease each year, according to the National Institute of Health. Chronic obstructive pulmonary disease, pneumonia, asthma, heart failure, and other cardiac and respiratory conditions all necessitate oxygen therapy, and critically ill patients, in particular, require high concentration respiratory masks.
Market Dynamics for High Concentration Respiratory Masks
The global market for high concentration respiratory masks is being driven by the rising incidence of respiratory diseases such as chronic obstructive pulmonary disease (COPD). Other major factors expected to drive the growth of the market for high concentration respiratory masks over the forecast period include technological advancements in the high concentration respiratory masks such as less use of breathing assistance, usability variance, and adjustable mask fit to the face.
Breathing problems are common in people over 60, necessitating the use of high concentration respiratory masks; thus, the growing geriatric population is expected to drive demand for high concentration respiratory masks.
Market for High Concentration Respiratory Masks: Regional Prospects
Because of the growing adoption of oxygen therapy masks for the treatment of various chronic respiratory disorders, North America is expected to see significant growth in the global market for high concentration respiratory masks. In Europe and Asia-Pacific, government initiatives for trauma and critical care patients are also driving the market for High Concentration Respiratory Masks. Because of the increased incidence of people suffering from asthma, chronic obstructive pulmonary disease, and other respiratory disorders, the increase in the geriatric population in Europe has a significant impact on market growth.
For List of Key Players and Full Segmentation, Ask for a Sample Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=2039